Fundraising Fox
🦊/People
Sign in

Misti Ushio

Investor

Managing Partner at Digitalis Ventures · Board director at Lodo Therapeutics · Board director at Senova Systems

New York, New York, United States

Find your path to Misti

163 people in our graph share verified history with Misti — schools, employers, funds. One of them is your warm intro.

Catherine Pearce, DHSc, MBAunlockedMisti: together at Merck (1999–2002)
×2Misti: together at Columbia University
×5Misti: together at Merck
Misti: together at Digitalis Commons

About

Dr. Misti Ushio is a Managing Partner at Digitalis Ventures with over 25 years in biotech, pharma, and early-stage life science company building. She was previously CEO of TARA Biosystems (acquired by ValoHealth in 2022), Chief Strategy Officer and Managing Director at Harris & Harris Group, and held roles at Merck and Columbia University.

Contact· self-published, not guessed

Invests in

BiotechDigital Health

Board director at Lodo Therapeutics

Intro paths

→

In turn, Misti can intro founders to Lodo Therapeutics's investors below.

Lodo Therapeutics's investors · 5

AbbVieCambridge · $300K – $3M checksAlexandriaPasadenaARCH Venture PartnersChicago · $50K – $250M checksDigitalis VenturesNew York · $100K – $10M checks · since 2015Pfizer Venture Investments$5M – $20M checks

Board director at Senova Systems

Intro paths

→

In turn, Misti can intro founders to Senova Systems's investors below.

Senova Systems's investors · 2

Digitalis VenturesNew York · $100K – $10M checks · since 2016Phoenix Venture PartnersSan Mateo · $100K – $3M checks · since 2016

Experience

  1. Digitalis VenturesManaging Partnercurrent2023 — presentNew York City
  2. Digitalis CommonsBoard Directorcurrent2023 — present
  3. TARA BiosystemsCEO2016 — 2022New York City, New York
  4. Harris & Harris GroupManaging Director & Chief Strategy Officer2011 — 2016
  5. Harris & Harris Group, Inc.Vice President2007 — 2011
  6. Columbia UniversityTechnology Licensing Officer2006 — 2007
  7. MerckSenior Research Chemical Engineer1995 — 2006

Skills & more

Biotechnology46Life Sciences36Business Strategy22Strategy23Venture Capital29Start-ups20Commercialization15Technology Transfer14Entrepreneurship9Pharmaceutical Industry7Corporate Development6Mergers & Acquisitions6
+11 moreResearchDue DiligencePrivate EquityMedical DevicesLifesciencesBiopharmaceuticalsNanotechnologyR&DManagementInvestmentsInnovation Management

From Misti's professional profile.

Deals · 3

Gallant PetBoard seat

via Digitalis Ventures · filed Jul 2025 · $18M raise

Lodo TherapeuticsBoard seat

via Digitalis Ventures · filed Jan 2017 · $19.9M raise

Senova SystemsBoard seat

via Digitalis Ventures · filed Jan 2016 · $600K raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Digitalis Ventures

Amit Bansal
Partner at Digitalis Ventures
Ben Jacobs
Partner at Digitalis Ventures
Bo Stewart
Associate at Digitalis Ventures
Cindy Cole
Technical Partner at Digitalis Ventures
Dac Nguyen
Technical Partner at Digitalis Ventures
Drew Taylor
Partner at Digitalis Ventures
Dylan Henderson
Accounting Manager at Digitalis Ventures
Geoffrey Smith
Founder / Managing Partner at Digitalis Ventures

Frequently asked questions

Who is Misti Ushio?
Dr. Misti Ushio is a Managing Partner at Digitalis Ventures with over 25 years in biotech, pharma, and early-stage life science company building. She was previously CEO of TARA Biosystems (acquired by ValoHealth in 2022), Chief Strategy Officer and Managing Director at Harris & Harris Group, and held roles at Merck and Columbia University.
Where does Misti Ushio work?
Misti Ushio is Managing Partner at Digitalis Ventures and Board director at Lodo Therapeutics and Board director at Senova Systems.
What does Misti Ushio invest in?
Misti Ushio invests in Biotech, Digital Health.
What boards does Misti Ushio sit on?
Misti Ushio holds tracked board seats at Gallant Pet, Lodo Therapeutics, Senova Systems.
Where did Misti Ushio go to school?
Misti Ushio studied at The Johns Hopkins University (BS, Chemical Engineering); UCL (PhD, Biochemical Engineering).

Same school

Shared employers